Projects per year
Fingerprint
Dive into the research topics where Anita Mesic is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Nontuberculous mycobacteria pulmonary disease and tuberculosis-nontuberculous mycobacteria co-infection: Epidemiology, diagnosis, and management at a tertiary health facility in Ghana
Abbew, E. T., Lynen, L., Mesic, A., Decroo, T., Rigouts, L., Obiri-Yeboah, D. & Lorent, N.
1/01/22 → …
Project: PhD-project
-
Alternative methodological approaches to assess longterm HIV virological and clinical outcomes in resource limited settings
Mesic, A., Lynen, L., Decroo, T., van Olmen, J. & Ritmeijer, K.
27/04/21 → 8/02/24
Project: PhD-project
Research output
-
Body mass index trajectories and association with Tuberculosis risk in a cohort of household contacts in Southern Africa
ERASE TB consortium, 2025, (E-pub ahead of print) In: Clinical Infectious Diseases. 12 p., ciaf222.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open Access -
Alternative methodological approaches to assess long-term HIV virological and clinical outcomes in resource-limited settings
Mesic, A., 8-Feb-2024, Antwerpen: Universiteit Antwerpen. 179 p.Research output: Thesis › Doctoral dissertation - Doctoral dissertation
-
Challenges and knowledge gaps in the management of non-tuberculous mycobacterial pulmonary disease in sub-Saharan African countries with a high tuberculosis burden: a scoping review
Abbew, E. T., Lorent, N., Mesic, A., Wachinou, A. P., Obiri-Yeboah, D., Decroo, T., Rigouts, L. & Lynen, L., 2024, In: BMJ Open. 14, 10 p., e078818.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open Access -
Longevity of modified standard short treatment regimens for rifampicin-resistant tuberculosis
Decroo, T., Mesic, A. & Decuyper, I., 2024, In: Lancet Infectious Diseases. 24, 10, p. 1069-1071 3 p.Research output: Contribution to journal › Editorial
-
Short oral treatment regimens for rifampicin-resistant tuberculosis are safe and effective for young children: results from a field-based, non-randomised clinical trial from Kandahar, Afghanistan
Mesic, A., Decuyper, I., Ishaq, S., Azizi, T., Ziamal, FH., Amiri, S., Keus, K., Pyae, MT., Mangal, KM., Amirzada, HK., Rasooli, A., Aloudal, MR., Daldar, MZ. & Decroo, T., 2024, In: European Respiratory Journal. 63, 5, 5 p., 2400436.Research output: Contribution to journal › Editorial
Open Access